Virtual Screening and Optimization of Novel mTOR Inhibitors for Radiosensitization of Hepatocellular Carcinoma

BACKGROUND: Radiotherapy has an ameliorative effect on a wide variety of tumors, but hepatocellular carcinoma (HCC) is insensitive to this treatment. Overactivated mammalian target of rapamycin (mTOR) plays an important part in the resistance of HCC to radiotherapy; thus, mTOR inhibitors have potent...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Ying-Qi, Gu, Shuang-Xi, Chen, Yong-Shou, Gao, Xu-Dong, Ren, Yi-Xin, Chen, Jian-Chao, Lu, Yin-Ying, Zhang, Heng, Cao, Shuang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220363/
https://www.ncbi.nlm.nih.gov/pubmed/32440103
http://dx.doi.org/10.2147/DDDT.S249156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220363/
https://www.ncbi.nlm.nih.gov/pubmed/32440103
http://dx.doi.org/10.2147/DDDT.S249156

Ejemplares similares